Reproductive Health Care Information Shield (patient information disclosure limits)

New Jersey's 2022 shield law bars HIPAA covered entities from disclosing patients' communications and examination findings about lawful reproductive health care in civil, probate, legislative, or administrative proceedings without the patient's explicit written consent, and requires providers to tell patients they may withhold that consent. It also bars state entities from helping out-of-state investigations into care that is legal in New Jersey. An August 2026 amendment extends these protections to gender-affirming care.